We are thrilled to announce that ZeClinics will be attending the 22nd International Congress of the European Society of Toxicology In Vitro (ESTIV 2024) in Prague from June 3rd to June 6th. This year, the event is centered around the pivotal theme, ‘The Application of New Approach Methodologies (NAMs) in Drug Discovery and Drug and Chemical Safety Assessment’.
We are dedicated to position the zebrafish model as a NAM for the evaluation of developmental toxicity in drug discovery. That's why we are excited to present our latest research. Our senior scientist in toxicology, Anna Navarro, will represent ZeClinics at the event and showcase our innovative approach through our poster presentation:
Poster Title: "High Throughput Platform for the Validation and Application of Zebrafish Embryos for ICH S5 (R3)"
Stay tuned for more updates on our participation in ESTIV 2024 and don't miss the chance to learn about our groundbreaking research leveraging zebrafish embryos for toxicity assessment.
We look forward to connecting with you at ESTIV 2024 and exploring potential collaboration opportunities.
ZeClinics' participant:
Anna Navarro, Senior Scientist in Toxicology
Are you planning to attend the Conference?
Contact us to arrange a personal meeting
Schedule a meeting now
Event page22nd International Congress of the European Society of Toxicology In Vitro (ESTIV 2024)